PP 2.6 – 00043 Probing cell death pathways in response to NNRTI treatment using a THP-1 infection model

• P. Zuck,
• Z. Fang,
• B. Howell,
• U.M. Lim,
• C. Balibar

Affiliations

P. Zuck

Merck & Co., Inc., Rahway, NJ, USA

Z. Fang

Merck & Co., Inc., Rahway, NJ, USA

B. Howell

Merck & Co., Inc., Rahway, NJ, USA

U.M. Lim

Merck & Co., Inc., Rahway, NJ, USA

C. Balibar

Merck & Co., Inc., Rahway, NJ, USA